B. Jung

Evaluation of cell-free DNA approaches for multi-cancer early detection.

D. Berry, T. Yeatman, E. Fung, 2022, Cancer cell.

Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer.

M. Berger, S. Gnerre, J. Reis-Filho, 2017 .

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

David R. Jones, M. Ladanyi, E. Hubbell, 2019, Nature Medicine.

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.

G. Mills, M. Ladanyi, C. Paweletz, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

M. Ladanyi, E. Hubbell, C. Rudin, 2019, Nature Medicine.

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.

G. Mills, M. Ladanyi, C. Paweletz, 2019 .

Abstract 4342: Ultra-deep next generation sequencing (NGS) of plasma cell-free DNA (cfDNA) from patients with advanced lung cancers: results from the Actionable Genome Consortium

G. Mills, M. Ladanyi, C. Paweletz, 2016 .

Analytical validation of a multi-cancer early detection test with cancer signal origin using a cell-free DNA–based targeted methylation assay

E. Revenkova, M. Halks-Miller, Madhuvanthi Ramaiah, 2023, PloS one.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract LB297: Analytical validation of a tissue-free, multi-cancer, post-diagnosis cancer research test that uses cell-free DNA methylation profiling

R. Shaknovich, Pei-Yun Chang, S. Chai, 2023, Cancer Research.